Your browser doesn't support javascript.
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children.
Laub, Otto; Leipold, Georg; Toncheva, Antoaneta A; Peterhoff, David; Einhauser, Sebastian; Neckermann, Patrick; Borchers, Natascha; Santos-Valente, Elisangela; Kheiroddin, Parastoo; Buntrock-Döpke, Heike; Laub, Sarah; Schöberl, Patricia; Schweiger-Kabesch, Andrea; Ewald, Dominik; Horn, Michael; Niggel, Jakob; Ambrosch, Andreas; Überla, Klaus; Gerling, Stephan; Brandstetter, Susanne; Wagner, Ralf; Kabesch, Michael.
  • Laub O; Pediatric Office Laub, Rosenheim, Germany.
  • Leipold G; Pediatric Office Dr. Leipold, Regensburg, Germany.
  • Toncheva AA; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Peterhoff D; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Einhauser S; Institute of Clinical Microbiology and Hygiene, University Hospital, Regensburg, Germany.
  • Neckermann P; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Borchers N; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Santos-Valente E; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Kheiroddin P; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Buntrock-Döpke H; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Laub S; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Schöberl P; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.
  • Schweiger-Kabesch A; Pediatric Office Laub, Rosenheim, Germany.
  • Ewald D; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Horn M; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.
  • Niggel J; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
  • Ambrosch A; Pediatric Office Dr. Heuschmann & Dr. Ewald, Regenstauf, Germany.
  • Überla K; Pediatric Office Dr. Horn, Schönau, Germany.
  • Gerling S; Maganamed Limited, Regensburg, Germany.
  • Brandstetter S; Institute of Laboratory Medicine, Microbiology and Hygiene, Hospital of the Order of St. John, Regensburg, Germany.
  • Wagner R; Institute of Clinical and Molecular Virology, FAU Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Kabesch M; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.
Front Pediatr ; 9: 678937, 2021.
Article in English | MEDLINE | ID: covidwho-1477849
ABSTRACT

Background:

Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children.

Methods:

In a cross-sectional design, children aged 1-17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined.

Results:

We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed.

Conclusions:

Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Journal: Front Pediatr Year: 2021 Document Type: Article Affiliation country: Fped.2021.678937

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Language: English Journal: Front Pediatr Year: 2021 Document Type: Article Affiliation country: Fped.2021.678937